Already a member? Sign in
Category: Supplements
Most Popular Types: Glutathione (IV), Liposomal Glutathione, Glutathione nebulizer (Show all)
Generic Name: Glutathione
See also: Glutathione-ATP, Glutathione (IV), Glutathione Lotion, Glutathione Patch
Glutathione is an antioxidant that is produced in the liver, where it detoxifies harmful compounds so they can be excreted through the bile. It also helps maintain the integrity of red blood cells and protect white cells. It's digested very rapidly when given orally so IV is an alternate route.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| ALS (Amyotrophic Lateral Sclerosis) | 34 | 12 |
|
|
|
|
|
| Parkinson's Disease | 23 | 9 |
|
|
|
|
|
| General health | 12 | 4 |
|
|
|
||
| Other | 8 | 1 |
|
||||
| Fatigue | 4 | 0 | |||||
| MS (Multiple Sclerosis) | 3 | 2 |
|
|
See all 61 patients currently taking Glutathione
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Glutathione
| Nausea | 1 | |
|---|---|---|
| Pain in veins | 1 | |
| Parkinson's Disease | 1 |
Frequently reported dosages based on patients currently taking Glutathione. See all 53 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Did not seem to work | 23 | ||
| Expense | 11 | ||
| Other | 11 | ||
| Personal research | 7 | ||
| Course of treatment ended | 3 | ||
| Doctor's advice | 2 | ||
| Not indicated | 1 |
Adherence
Taking treatment as prescribed
Adherence of Glutathione
Always |
19 | 61% |
|
|---|---|---|---|
Usually |
6 | 19% |
|
Sometimes |
2 | 6% |
|
Never |
4 | 13% |
|
Burden
Difficulty being on treatment
Burden of Glutathione
Very |
5 | 16% |
|
|---|---|---|---|
Somewhat |
9 | 29% |
|
A little |
5 | 16% |
|
Not at all |
12 | 39% |
|
Cost
Paid out of pocket
Cost of Glutathione
$200+ |
10 | 48% |
|
|---|---|---|---|
$100-199 |
1 | 5% |
|
$50-99 |
2 | 10% |
|
$25-49 |
1 | 5% |
|
< $25 |
7 | 33% |
|
Report created on February 11, 2012.